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Afﬁnity chromatographyThe presence of endotoxins in preparations of recombinantly produced therapeutic proteins poses seri-
ous problems for patients. Endotoxins can cause fever, respiratory distress syndromes, intravascular
coagulation, or endotoxic shock. A number of methods have been devised to remove endotoxins from
protein preparations using separation procedures based on molecular mass or charge properties. Most
of the methods are limited in their endotoxin removal capacities and lack general applicability. We are
describing a biotechnological approach for endotoxin removal. This strategy exploits the observation that
endotoxins form micelles that expose negative charges on their surface, leading to preferential binding of
endotoxins to cationic surfaces, allowing the separation from their resident protein. Endotoxins exhibit
high afﬁnity to stretches of histidines, which are widely used tools to facilitate the puriﬁcation of recom-
binant proteins. They bind to nickel ions and are the basis for protein puriﬁcation from cellular extracts
by immobilized metal afﬁnity chromatography. We show that the thrombin-mediated cleavage of two
histidine tags from the puriﬁed recombinant protein and the adsorption of these histidine tags and their
associated endotoxins to a nickel afﬁnity column result in an appreciable depletion of the endotoxins in
the puriﬁed protein fraction.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Recombinant DNA technology and the development of efﬁcient
protein expression systems have led to the production and thera-
peutic deployment of a large number of biopharmaceuticals. More
than 200 biopharmaceuticals produced in bacteria, yeast, and
mammalian cell cultures have been approved by the regulatory
agencies. Roughly one-third of these molecules have been derived
from Escherichia coli, and most recombinant proteins are expressed
in the bacterial cytoplasm [1]. They can be directed to the peri-
plasm, deposited in the inner or outer membrane, or secreted in
the growth medium. The yield of bacterially expressed proteins
and their puriﬁcation procedures have been optimized by biotech-
nologists, and efﬁcient protocols associated with low costs have
been established [1–3].
A persistent problem associated with the production of recom-
binant proteins in bacteria is the presence of endotoxins in puriﬁed
protein preparations. Endotoxin removal from recombinant pro-
tein preparations often involves elaborate and expensive proce-
dures. In addition, such procedures lack general applicability and
can be limited in their endotoxin removal capacity. We wanted
to overcome these limitations and devise a general approach forthe endotoxin depletion of recombinantly expressed proteins.
Our endotoxin removal strategy from bacterially expressed pro-
teins is based on the preferential binding of endotoxins to a stretch
of cationic histidines and the possibility to absorb this polyhisti-
dine–endotoxin complex onto nickel afﬁnity columns.
Endotoxins are lipopolysaccharides (LPSs)1 and are an integral
part of the outer cell membrane of gram-negative bacteria [4]. They
consist of a lipid component (lipid A), a core oligosaccharide, and a
long heteropolysaccharide chain, the strain-speciﬁc bacterial surface
O-antigen [5–7]. Lipid A is thought to be responsible for most of the
biological activities of endotoxins [1,2]. Endotoxins are released on
bacterial cell death [3]. They are rather heat stable and can form
aggregates in the presence of divalent cations. The aggregates dis-
play negative charges on their surface and can be adsorbed to cat-
ionic materials through their phosphate groups [5].
Endotoxins can trigger strong biological reactions when intro-
duced into the bloodstream [6,8]. They can cause fever, hypoten-
sion, respiratory distress syndromes, intravascular coagulation,
and endotoxic shock. Sepsis is a systemic inﬂammatory responsereceptor;
th; PBS,
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lates the synthesis of the inﬂammatory cytokines IL-1b (interleu-
kin 1b), IL-6, IL-10, and TNF-a [1,4].
The molecular mechanisms that mediate endotoxin actions
have been well characterized. LPS can activate TLR4, a member of
the family of toll-like receptors (TLRs) expressed by cells of the
innate immune system that recognize structural motifs character-
istic of pathogen-associated molecular patterns (PAMPs) [9]. LPS
interaction with TLR4 is mediated by a number of additional pro-
teins (e.g., LPS binding protein [LBP], CD14, MD-2 [10,11]) and
eventually causes the expression of proinﬂammatory cytokines.
LPS mediates TLR4 oligomerization and the recruitment of down-
stream adaptor molecules such as MyD88 (myeloid differentiation
primary response gene 88), TIRAP (TIR domain-containing adaptor
protein), TRIF (TIR domain-containing adaptor-inducing IFN-b),
TRAM (TRIF-related adaptor molecule), and SARM (sterile alpha
and HEAT/Armadillo motif-containing protein) [12].
LPS induction of the TLR4 receptor complex (e.g., in macro-
phages) activates intracellular signal transduction pathways and
autocrine and paracrine signaling events. The p38 MAPK and Stat3
signal transduction pathways play central roles. They control the
induction and duration of the inﬂammatory macrophage response
[13–15]. Because LPS is a strong activator of Stat3, we used the
treatment of macrophages and the phosphorylation status of Stat3
as a read-out for LPS-induced signaling and compared recombinant
protein preparations before and after the depletion procedure. We
expect that the depletion of LPS in the rS3-PA protein preparation
causes reduced Stat3 phosphorylation.
Gram-negative bacteria release endotoxins when their cell wall
is disrupted by sonication during the lysis process. The protein
puriﬁcation steps need to take this into account, and therapeutic
proteins must be shown to be free of endotoxins before they can
be used.
A number of methods have been described for the removal of
endotoxins from recombinant proteins [6,16]. Diverse separation
procedures such as ultraﬁltration, anion exchange chromatogra-
phy, membrane-based chromatography, polymyxin B immobilized
on Sepharose 4B, and the application of two-phase micellar sys-
tems have been employed [5,6]. In addition, the use of activated
charcoal, modiﬁed cellulose, and chitosan microﬁltration mem-
branes are being considered [7]. The methods used to remove
endotoxins often employ detergents combined with phase separa-
tion and afﬁnity chromatography and need to be adjusted to the
biochemical properties of the protein to be puriﬁed (e.g., the amino
acid composition and the charge properties) [17]. There is cur-
rently no method available that can be generally used for all bacte-
rially expressed proteins.
Endotoxin concentrations during the protein puriﬁcation pro-
cess can be independently monitored by the limulus amebocyte
lysate (LAL) test (e.g., from Charles River Laboratories) [18]. In
the presence of endotoxins, the hemolymph of the limulus poly-
phemus agglutinates. There are several test kits available with dif-
ferent sensitivities and also chromogenic assays in which the
concentration of LPS can be determined.
We established a strategy for endotoxin removal from bacterial
lysates with a model protein. This protein is a peptide aptamer
construct, rS3-PA. It incorporates a short peptide sequence that
speciﬁcally recognizes and inhibits the function of the transcrip-
tion factor Stat3 [19–22]. The construct encoding rS3-PA is shown
in Fig. 1. The Stat3 recognizing peptide sequence is embedded in
the human thioredoxin, which serves as a scaffold protein. It also
contains histidine tags, 10 consecutive histidine residues, at its
amino and carboxyl termini. We hypothesized that the contami-
nating endotoxins are mainly associated with the histidine tags
[7,23] used in our strategy for the endotoxin depletion of proteins
produced in E. coli and puriﬁed from the bacterial lysates. Weintroduced two thrombin cleavage sites next to the histidine tags.
We compared the endotoxin activity in the rS3-PA preparations
before and after the cleavage and a second step of nickel afﬁnity
chromatography. We observed a drastic LPS depletion in the
recombinant protein fraction devoid of the histidine tags. The
depleted protein contains highly reduced LPS content and is not
able to induce Stat3 activation in macrophages.Materials and methods
Insertion of thrombin recognition motifs into the pET 30 a+ bacterial
expression vector
Thrombin is a protease with an important role in blood coagu-
lation. It recognizes the amino acid sequence Leu-Val-Pro-Arg/Gly-
Ser and cleaves between the arginine and glycine residues. We
designed oligonucleotides of the following sequences and used
them to introduce thrombin cleavage sites into the bacterial
expression vector:
Thrombin_fwd (Sigma–Aldrich, Taufkirchen, Germany):
GAATTCAGAAGAAGAAGAAGAAGAAGAAGAAGACTGGTGCCACG
CGGTTCTGGTCATCATCATCATCATCATCATCATCATCATTAACTCG
AG
Thrombin_rev (Sigma–Aldrich): CTCGAGTTAATGATGATGATG
ATGATGATGATGATGATGACCAGAACCGCGTGGCACCAGTCTTCTT
CTTCTTCTTCTTCTTCTTCTGAATTC.
These oligonucleotides were annealed in a buffer consisting of
100 mM NaCl and 50 mM Hepes (pH 7.4). In a ﬁrst step, the reac-
tion was denatured at 95 C for 10 min, and thereafter the temper-
ature was decreased every 2 min by 5 C until the temperature
reached 4 C. These oligonucleotides were then restricted with
EcoRI (New England Biolabs, Ipswich, MA, USA) and XhoI (New Eng-
land Biolabs), run on a 2% agarose gel, isolated, and puriﬁed. These
restricted oligonucleotides were then inserted into the pET 30 a+
vector and digested with EcoRI and XhoI. Ligation with T4 ligase
(New England Biolabs) at 16 C overnight led to an insertion of
the thrombin recognition motif between the C terminus of the pro-
tein and the histidine tag (Fig. 1).Transformation in BL21-CodonPlus (DE) bacteria
The rS3-PA gene was cloned into bacterial expression vectors,
pET 30 a+ for thrombin cleavage and pFlag as a control vector with
only one histidine tag at the carboxyl terminus. The plasmids were
transformed into BL21-CodonPlus bacteria (Stratagene, Agilent
Technologies, Santa Clara, CA, USA). These bacteria are speciﬁcally
suited for high-yield protein expression based on the strength of
the T7 promoter. For the transformation process, 100 ll of Top10
F0 bacteria was thawed on ice for 15 min. Then 5 ll of H2O and
5 ll of the ligation reaction were transferred into a 1.5-ml tube
on ice. Next 100 ll of the bacteria was added and carefully mixed
without vortexing. The mixture was kept on ice for approximately
30 min. Thereafter, the mixture was heat shocked at 42 C for
1 min and subsequently incubated on ice for 2 min. Then 1 ml of
LB (Luria–Bertani broth) medium at room temperature was added.
This solution was incubated at 37 C for 1 h and shaking at
350 rpm. The mixture was centrifuged for 1 min at 12,000 rpm,
and the supernatant was removed except for 50 ll. This 50 ll
was used to resuspend the bacterial pellet, and the bacteria were
plated on agar dishes containing 50 lg/ml kanamycin (AppliChem,
Darmstadt, Germany). The plates were left to dry and ﬁnally incu-
bated at 37 C overnight.
Fig.1. Experimental strategy described in this article to obtain recombinant protein preparation largely free of contamination endotoxins. The procedure is based on the
introduction of thrombin cleavage sites between amino terminal and carboxy terminal histidine tags and a recombinant protein of interest. The pET 30 a+ bacterial expression
vector is equipped with an endogenous N-terminal thrombin recognition site. A second site was introduced at the C terminus by oligonucleotide insertion, represented by the
thrombin cleavage motif (LVPRGS). Removal of the histidine tags on thrombin cleavage and nickel chromatography leads to reduced endotoxin levels in the puriﬁed
recombinant protein preparation.
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A 20-ml LB medium preculture containing 50 lg/ml kanamycin
was inoculated with one bacterial clone. After 5 to 8 h at 37 C with
200 rpm, this preculture was transferred into 1 to 2 L of TB (Terriﬁc
Broth) medium. Chloramphenicol (Sigma–Aldrich, 50 lg/ml) was
also added to ensure that the pACYC plasmid stays within the
strain. This plasmid is essential for the survival of the BL21-Codon-
Plus bacteria. The bacterial culture was than incubated overnight
at 200 rpm and 37 C until the optical density at 600 nm reached
a value between 4 and 5. Then the bacteria were collected by cen-
trifugation at 4000 rpm for 20 min.Protein puriﬁcation
The pelleted bacteria were resuspended in 30 ml of buffer A
(8 M urea [AppliChem], 500 mM NaCl [AppliChem], and 1 phos-
phate-buffered saline [PBS, Life Technologies, Darmstadt, Ger-
many], pH 7.5) per 500 ml of TB culture medium on ice. The
lysate was sonicated three times on ice for 1 min with an output
control of 3 W and at a duty cycle of 70% with a homogenizer (Ultra
Turray T 25, IKA Werke, Staufen, Germany) to disrupt the cells. The
sonicated lysate was centrifuged at 9500 rpm for 30 min at 4 C.
The supernatant was ﬁltered with paper and transferred to the
superloop of the Äkta FPLC (fast protein liquid chromatography)
device (GE Healthcare, Freiburg, Germany). The puriﬁcation pro-
cess is based on nickel afﬁnity chromatography. For this purpose,
a HiTrap 1-ml chelating column from GE Healthcare was ﬁrst
washed with 5 ml of buffer A for equilibration and then loaded
with 1 ml of 0.1 M NiSO4 solution. The analysis program used on
the Äkta FPLC device was Unicorn 4.11.
After loading the protein solution to the superloop, the protein
was channeled through the nickel-loaded column at a speed of
1 ml/min to ensure efﬁcient binding. Unbound protein was washed
out by additional buffer A running over the HiTrap column and col-
lected. In the next step, nonspeciﬁcally bound proteins were
washed from the column by increasing the concentration of imid-
azole (AppliChem) in buffer B (8 M urea, 500 mMNaCl, 1 PBS, and
1 M imidazole, pH 7.5), which was used to wash the HiTrap col-umn. This was done in two gradient shifts. The ﬁrst one increased
the imidazole concentration from 0 to 40 mM, and the second one
shifted it from 40 to 80 mM. To elute the bound histidine-tagged
proteins from the column, the concentration of imidazole was
increased to 300 mM. Increasing imidazole concentrations result
in higher stringency of binding of histidine-tagged proteins to
NiSO4. The eluted proteins were collected in 1-ml fractions and
stored on ice.
Dialysis
The protein concentrations in the eluted fractions were deter-
mined by Bradford assays, and the ones that exceeded 2 lg/ll were
pooled. They were transferred into a dialysis bag (Snake Skin,
Thermo Fisher Scientiﬁc, Dreieich, Germany) that left the protein
enough space to ﬂoat. The dialysis was performed with 400 mM
arginine, 250 mM NaCl, and 10% glycerol (AppliChem) at pH 7.5
in PBS for 20 h at 4 C. During this process, the dialysis was slowly
rotating. The concentration of the proteins in the dialysis bags was
at least 2 lg/ll during the process.
The dialyzed protein was then dialyzed a second time in a solu-
tion containing 50 mM Tris and 300 mM NaCl at pH 7.5 (cleavage
buffer) in preparation for the thrombin cleavage [8]. The dialysis
was performed at 4 C with slow rotation overnight. The next
morning, 25% of the dialysis buffer was replaced every 2 h with
10% glycerol and PBS. This led to a gradual reduction in the concen-
tration of salts and arginine in the ﬁnal protein preparation, a
requirement for the refolding process. After four exchanges of dial-
ysis buffer against glycerol and PBS, the whole dialysis bath had
been exchanged and the dialysis process was ﬁnished. The protein
was centrifuged at 4 C and 9500 rpm for 30 min to remove precip-
itated material. The protein was then split into 500-ll aliquots and
frozen at 20 C.
Thrombin cleavage
The protocol for thrombin cleavage followed the description by
Hefti and coworkers [24]. Thrombin (Sigma–Aldrich) was dissolved
in 50 mM Tris, 300 mM NaCl, and 2.5 mM CaCl2 (AppliChem) at pH
Fig.2. Thrombin cleavage of the recombinant protein constructs. (A) The enzymatic process was performed at 1:50 or 1:500 molar ratios of rS3-PA to thrombin. The cleavage
at the 1:500 ratio was more efﬁcient, and the indicative cleavage products could be observed after 3 h of incubation. (B) The graph demonstrates that the cleavage is
approximately 70% complete after 3 h of incubation and is nearly 100% complete after 96 h. (C) Incubating the puriﬁed proteins hTrx and rS3-PA containing the two histidine
tag recognition motifs with recombinant thrombin for 16 h at 37 C results in a complete cleavage of histidine tags, which were subsequently removed by a second step of
afﬁnity chromatography. Signals can be observed after incubation with an anti-hTrx antibody; the histidine-tag-speciﬁc antibody does not detect the cleaved recombinant
protein. The removal of the histidine tags slightly reduced the proteins in size. (D) The cleavage and removal of the histidine tags was also conﬁrmed by Coomassie blue
staining of the gels.
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unit = 0.324 ± 0.073 lg) (Sigma–Aldrich). The rS3-PA peptide apt-
amer was incubated with thrombin in a molar ratio of 1:500 for
different lengths of time at 37 C in a heating block. At indicated
time points (3, 24, 48, 72, and 96 h), 100-ll aliquots were taken
for analysis. The uncleaved rS3-PA and the samples taken at the
different time points were loaded onto a 15% SDS–PAGE (sodium
dodecyl sulfate–polyacrylamide gel electrophoresis) gel, and Wes-
tern blotting was performed. The protein was detected with an
anti-human thioredoxin antibody (Cell Signaling, Danvers, MA,
USA) in Western blot analysis, which still contained both rS3-PA
versions (Figs. 1 and 2A).Removal of cleaved histidine tags
The proteins cleaved by thrombin were subjected to a second
round of nickel afﬁnity chromatography. This allowed the separa-
tion of rS3-PA from the histidine tags. The removal of the histidine
tags was conﬁrmed by Western blotting analyses with anti-human
thioredoxin and anti-histidine tag antibodies.ig.3. Measurement of endotoxin concentrations in the recombinant protein
reparations by the LAL assay. In all cases, a total of 80 lg of protein was used.
he initial 80 lg was then diluted 1:100, 1:1000, and 1:10,000 with endotoxin-free
ater. The experiment was performed according to the manufacturer’s guidelines,
nd the results were obtained by measuring the absorbance at 545 nm. Calculating
e concentration of endotoxins was also done in accordance with the manual with
e formula 0.2618 * x  0.0012 (where x is the adsorbance at 545 nm of each
mple). The cleaved proteins show signiﬁcantly reduced concentrations of
ndotoxins when compared with their uncleaved counterparts.Cell culture
The murine macrophage cell line RAW 264.7 responds to the
exposure to endotoxin with the activation of the transcription fac-
tor Stat3. This can be visualized by a speciﬁc antibody that recog-
nized tyrosine phosphorylated Stat3. These cells were used to
show the removal of endotoxin from the puriﬁed rS3-PA prepara-
tions. The cells were seeded in 6-well plates and cultivated to
attach overnight. The next day, they were used for Stat3 induction
experiments. Cells were treated with LPS (Sigma–Aldrich, 500 g/
ml), rS3-PA (uncleaved pET), rS3-PA (uncleaved pFLAG), rS3-PA(cleaved 1:50), or rS3-PA (cleaved 1:500) or were not treated at
all for 6 h. Afterward, whole cell lysates were prepared and a Wes-
tern blot was performed with 35 lg of protein.Antibodies
Speciﬁc antibodies were incubated with the nitrocellulose Wes-
tern blot membrane with 5% bovine serum albumin (BSA) in 0.1%
TBS-T (Tris-buffered saline with 0.01% Tween 20) (1:1000) at 4 C
overnight to allow binding. We used P-Stat3 (XP, Cell Signaling),F
p
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a
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HIS (HIS tag antibody which recognizes tags comprised of six
histidine residues; Sigma–Aldrich), actin (Sigma–Aldrich), and
tubulin (Sigma–Aldrich). The secondary antibody directed against
rabbit antibodies was obtained from Cell Signaling, and anti-mouse
antibodies were obtained from Sigma–Aldrich.Determination of endotoxins
In this work, the endotoxin content was veriﬁed with the Tox-
inSensor Chromogenic LAL Endotoxin Assay Kit (Genscript, Piscat-
away, NJ, USA). This test was performed and the concentrations of
endotoxin were calculated according to the manufacturer’s guide-
lines (Fig. 3) with the formula 0.2618 * x  0.0012 (where x is the
adsorbance at 545 nm of each sample).Fig.4. rS3-PA devoid of its histidine tags shows signiﬁcantly reduced endotoxin
contamination as visualized by the capacity to activate Stat3 in murine macro-
phages. RAW 264.7 cells either were left untreated or were treated with LPS
(500 ng/ml), rS3-PA (uncleaved, pFLAG, 2 lM), rS3-PA (uncleaved, pET, 2 lM), rS3-
PA (cleaved with thrombin in a molar ratio of 1:500, 2 lM), or rS3-PA (cleaved with
thrombin in a molar ratio of 1:50, 2 lM). The LPS stimulation (lane 2) led to
induction of phosphorylation of Stat3 to a similar extent as the uncleaved proteins
(lanes 3 and 4). Both cleaved versions of rS3-PA resulted in a much lower level of P-
Stat3 (lanes 4 and 5). Ab, antibody.Results and discussion
Introduction of thrombin cleavage sites into expression vector of
recombinant Stat3 peptide aptamer (rS3–PA)
The gene encoding the recombinant protein, rS3-PA, was
inserted into a pET30 a+ bacterial expression vector and histidine
tags, 10 consecutive histidine residues, were added to the amino
and carboxyl termini. In addition, thrombin cleavage sites were
inserted (LVPR/GS) between the histidine tags and the termini of
the rS3-PA protein (Fig. 1). The resulting protein was expressed
at high levels in E. coli and puriﬁed by nickel afﬁnity chromatogra-
phy as described in detail in earlier publications [19–21]. These
protein fractions still contained appreciable levels of endotoxins.
We hypothesized that the contaminating endotoxins were primar-
ily associated, and thus copuriﬁed, with the histidine tags [7,23].
For this reason, we devised a strategy in which we separated the
puriﬁed protein from the histidine tags and the contaminating
endotoxins.
The procedure entails a two-step protocol. In a ﬁrst step, the
rS3-PA sequence is cleaved from the histidine tags through the
enzymatic action of thrombin. In a second step, the liberated histi-
dine stretches and their associated endotoxins were separated
from the recombinant protein by afﬁnity chromatography to
immobilized nickel ions. The thrombin cleavage reaction was mon-
itored after increasing times of digestion, and protein samples
were analyzed by Western blot analysis and quantiﬁed by ImageJ
(Fig. 2A and B) [9]. The antibody speciﬁc for the human thioredoxin
scaffold, into which the peptide aptamer had been inserted, recog-
nized both the original rS3-PA protein and the cleaved version. The
thrombin cleavage seems to be complete after 24 h of incubation
(Fig. 2A). The histidine tag-speciﬁc antibody recognizes the original
rS3-PA but not the thrombin-cleaved product, which is devoid of
histidine tags after the thrombin cleavage (Fig. 2C). The peptide
aptamer rS3-PA and the rS3-PA devoid of histidine tags differ in
size by approximately 2 kDa. The Coomassie staining pattern of
the gel shown in Fig. 2D conﬁrms the predicted size differences
between the rS3-PA versions before and after the thrombin cleav-
age. These results demonstrate that the histidine tags can be efﬁ-
ciently cleaved from the recombinant protein.
We subjected the thrombin-cleaved rS3-PA to a second round of
nickel afﬁnity chromatography. Because the afﬁnity for the nickel
column is dependent on the histidine tags, the thrombin-cleaved
rS3-PA is not expected to be retained and should elute with the
ﬂow-through. The histidine tags themselves, however, should be
retained and, thus, should be separated from the rS3-PA moiety.
Endotoxins have a strong afﬁnity to the histidine residues, and it
can be expected that they are preferentially retained on the nickel
column during the second chromatography step [10]. Thrombincleavage and a second round of nickel afﬁnity chromatography
separate rS3-PA from the histidine tags and should cause a strong
endotoxin depletion.
We tested whether the cleavage process and the second nickel
column resulted in a reduction of endotoxins in the rS3-PA fraction
devoid of the histidine tags. For this purpose, we used the LAL
assay. This assay is widely used to detect and quantitate endotox-
ins originating from gram-negative bacteria. In our experiments, a
chromogenic LAL test (Toxic Sensor Chromogenic LAL Endotoxin
Assay Kit, Genscript) was used to determine the amount of endo-
toxins (Fig. 3). This test demonstrated that the preparation of the
thrombin-cleaved version of rS3-PA, obtained in the ﬂow-through
of the second nickel column, contains approximately 10-fold less
endotoxins than the rS3-PA preparation retained on the column
after the ﬁrst chromatography step. It also indicates that the endo-
toxins are primarily associated with the histidine tags.Thrombin-cleaved rS3-PA is devoid of Stat3 phosphorylating activity
Because we observed variable extents of Stat3 inhibition by rS3-
PA in earlier experiments, depending on particular protein prepa-
rations [22], we suspected that the residual endotoxins present
in these preparations might be the cause. The endotoxins can
counteract the inhibitory rS3-PA function and induce the activa-
tion of the target molecule Stat3 through the TLR pathway and
by the induction of autocrine IL-6 stimulation. Therefore, we mea-
sured Stat3 activation in macrophages exposed to rS3-PA with or
devoid of the histidine stretches and their associated LPS. For this
purpose, we treated RAW 264.7 cells with uncleaved or throm-
bin-cleaved rS3-PA preparations. Stat3 can be activated in this
murine macrophage cell line on exposure to LPS. The cells were
cultivated and incubated with medium, LPS (500 ng/ml), uncleaved
rS3-PA (pET, 2 lM), uncleaved rS3-PA (pFlag, 2 lM), cleaved rS3-
PA (2 lM, 1:500 ratio), and cleaved rS3-PA (2 lM, 1:50 ratio) for
6 h. Afterward, the cells were harvested, protein extracts were pre-
pared, and Stat3 activation was analyzed by Western blotting with
a phospho-Stat3-speciﬁc antibody.
We observed that Stat3 activation could be achieved by treating
the cells with LPS (500 ng/ml). A similar extent of Stat3 activation
was found when the cells were exposed to uncleaved rS3-PA
(Fig. 4, lanes 3 and 4). However, no activation of Stat3 was detected
in cells treated with rS3-PA cleaved with thrombin and subjected
to a second round of afﬁnity chromatography (Fig. 4, lanes 5 and
88 Removal of endotoxins from recombinant proteins / L. Mack et al. / Anal. Biochem. 466 (2014) 83–886). This conﬁrms the LAL-based endotoxin assays and indicates
that the two-step puriﬁcation procedure allows a drastic depletion
of contaminating LPS.Concluding remarks
This study demonstrates a new approach to reduce the amount
of endotoxins in bacterially expressed proteins in a relatively
cheap and time-saving fashion. It is based on the introduction of
thrombin cleavage sites between the protein of interest and the
histidine tags used for the puriﬁcation of the recombinant protein
by nickel afﬁnity chromatography. On a ﬁrst step of nickel afﬁnity
chromatography, in which the recombinant protein is retained on
the column, thrombin treatment is used to cleave off the histidine
tags. The cleaved protein is subjected to a second round of nickel
afﬁnity chromatography in which the histidine tags and associated
endotoxins, but not the recombinant protein of interest, are
retained. The protein, depleted from endotoxins, can be recovered
in the ﬂow-through. This approach will be applicable for many dif-
ferent proteins independent of their amino acid composition or
electrostatic properties. We demonstrated that this strategy can
be successfully employed for a membrane-permeating Stat3
inhibitor.
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